Health ❯ Healthcare

Immunotherapy

Cancer Treatment Cancer Immunotherapy Checkpoint Inhibitors Cancer Vaccines mRNA Technology T-cell Therapy Personalized Medicine Vaccine Development Clinical Trials CAR-T Therapy

AstraZeneca’s Imfinzi–Imjudo Regimen Improves Progression-Free Survival in Liver Cancer Trial

The approach starts immunotherapy before a chemoembolization procedure to help keep tumors in check earlier.

Autolus Reports Q4 Loss, Reaffirms 2026 Sales Outlook for AUCATZYL, and Starts AUTO8 Trial

EU Drug Panel Backs Imdylltra for Relapsed Small Cell Lung Cancer

Enlivex Raises $21 Million, Buys 3 Billion RAIN Tokens at a Discount

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

EU Grants Conditional Approval for ImmunityBio’s Anktiva in BCG‑Unresponsive Bladder Cancer

DNA Origami Vaccine Scaffold Sharply Focuses HIV Immune Response in Preclinical Study

Morning Immunotherapy Boosts Survival in Lung Cancer Trial

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

First NHS Patient Completes Next‑Generation CAR‑T Therapy for Aggressive Leukaemia

FDA Issues Second Rejection of Atara’s EBV+ PTLD Therapy Tabelecleucel

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Shorter, Chemo-Free Strategies Match or Beat Standard Care in Adult Leukemias at ASH

Vaccimel, Argentina's Melanoma Immunotherapy, Enters Commercial Use

FDA Approves Durvalumab Added to Perioperative FLOT for Resectable Gastric and GEJ Cancer

Study Pinpoints GPR25 as Switch for Tissue-Resident Memory T Cell Formation

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

Study Identifies Early Epigenetic 'Big Bang' of Immune Escape in Bowel Cancer

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds